Chemistry and Industry

1. Calls for tighter nanotechnology regulation.(Brief article)
A former US Environmental Protection Agency (EPA) official says nanotechnology should be more tightly regulated. In his report, EPA and Nanotechnology: Oversight for the 21st ...
(PREMIUM PERIODICAL ARTICLE)

2. NICE endorses scheme for NHS to only pay for drugs that work.
Analysts have welcomed what is the first of its kind endorsement by UK health watchdog National Institute for Health and Clinical Excellence (NICE) of a ...
(PREMIUM PERIODICAL ARTICLE)

3. European production levels up in Q1 2007.(Chemicals)
Chemical production in Europe grew by 1.25% in Q1 2007, compared with 0.5% in the US and Japan, to give an overall 0.7% growth across ...
(PREMIUM PERIODICAL ARTICLE)

4. Toxic ships give UK a wide berth.(Ship dismantling)(Brief article)
US government plans to have former US Navy ships containing large amounts of hazardous chemicals dismantled in the UK will not now go ahead. The ...
(PREMIUM PERIODICAL ARTICLE)

5. High profile.(Brief article)
A new company profile service, www.chemicalcompanyprofiles. com, has been launched to provide customisable reports in Microsoft PowerPoint format. This approach has been adopted to facilitate ...
(PREMIUM PERIODICAL ARTICLE)

6. Hope for liver cancer.(Brief article)
For the first time, scientists claim to have created a treatment that improves survival in liver cancer. Liver cancer, which is diagnosed in half a ...
(PREMIUM PERIODICAL ARTICLE)

7. Elan's ceo lashes out over drug prices; Ellan ceo Kelly Martin's...
A rein on the price of new pharmaceutical drugs is unlikely, despite recent comments from one chief executive officer. Elan Corp's ceo Kelly Martin was ...
(PREMIUM PERIODICAL ARTICLE)

8. Price fall in store for organic apples.(Food preservation)
A new technique that uses short bursts of low oxygen to prolong the life of organic fruit could see costs of organic produce drop close ...
(PREMIUM PERIODICAL ARTICLE)

9. Challengers to Acomplia.(News)(Brief article)
Sanofi-Aventis' new anti-obesity drug could be facing. challenges from generics before it is even approved in mator developed countries reports the French newspaper Les Echos.
(PREMIUM PERIODICAL ARTICLE)

10. Molecular diagnostics.(Pharma in brief)(Brief article)
Dutch diagnostics maker Qiagen has agreed to buy US firm Digene Corp for about $1.6bn in cash (55%) and stock (45%), in a deal that ...
(PREMIUM PERIODICAL ARTICLE)